Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed |
|---|---|---|
|
Neurogene Inc
13G
NGNE · 64135M105
|
11.1% |
10/6/2026
Event 9/30/2026
|
|
Palvella Therapeutics Inc
13G
PVLA · 697947109
|
6.7% |
8/3/2026
Event 6/30/2026
|
|
Acadian Asset Management Inc
13G/A
AAMI · 10948W103
|
4.3% |
8/3/2026
Event 6/30/2026
|
|
Summit Hotel Properties Inc
13G/A
INN · 866082100
|
10.8% |
7/2/2026
Event 6/30/2026
|
|
Cabaletta Bio Inc
13G/A
CABA · 12674W109
|
11.4% |
6/4/2026
Event 5/29/2026
|
|
Lendingtree Inc
13G
TREE · 52603B107
|
7.4% |
5/6/2026
Event 3/31/2026
|
|
Tarsus Pharmaceuticals Inc
13G/A
TARS · 87650L103
|
4.0% |
5/6/2026
Event 3/31/2026
|
|
Riskified Ltd-A
13G/A
RSKD · M8216R109
|
0.7% |
5/6/2026
Event 3/31/2026
|
|
Heritage Financial Corp
13G/A
HFWA · 42722X106
|
7.8% |
5/6/2026
Event 3/31/2026
|
|
GREAT LAKES DREDGE & DOCK CO
13G/A
GLDD · 390607109
|
1.5% |
5/6/2026
Event 3/31/2026
|
|
Arcutis Biotherapeutics Inc
13G/A
ARQT · 03969K108
|
4.0% |
5/6/2026
Event 3/31/2026
|
|
Plymouth Industrial REIT Inc
13G/A
PLYM · 729640102
|
3.4% |
1/30/2026
Event 12/31/2025
|
|
Midwestone Financial Group I
13G/A
MOFG · 598511103
|
2.5% |
1/30/2026
Event 12/31/2025
|
|
Cava Group Inc
13G/A
CAVA · 148929102
|
0% |
11/5/2025
Event 9/30/2025
|
|
Phathom Pharmaceuticals Inc
13G/A
PHAT · 71722W107
|
0% |
6/9/2025
Event 5/31/2025
|
|
Bridge Investment Grp HDS-A
13G/A
BRDG · 10806B100
|
3.3% |
5/8/2025
Event 3/31/2025
|
|
Adecoagro SA
13G/A
AGRO · L00849106
|
4.1% |
5/8/2025
Event 3/31/2025
|
|
Shift4 Payments Inc-Class A
13G/A
FOUR · 82452J109
|
3.4% |
2/11/2025
Event 12/31/2024
|